CoChat
Sign Up
Cited by 167HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and OutcomesHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Amphetamine-group substances and HIV

Colfax, Grant, Santos, Glenn-Milo, Chu, Priscilla, Vittinghoff, Eric, Pluddemann, Andreas, Kumar, Suresh, Hart, Carl·2010·The Lancet
DOI 10.1016/s0140-6736(10)60753-2
Open this paper in CoChat — free account

Abstract

Amphetamine-group substances are used worldwide and are more prevalent than either cocaine or opioids. We reviewed published reports about amphetamine-group substances and did a meta-analysis of randomised controlled trials of behavioural interventions for their use. Most research was done in developed countries. Many, but not all, studies show an association between amphetamine-group substance use and risk of HIV infection. Much use of amphetamine-group substances is non-injection and is associated with increased HIV risk, particularly in men who have sex with men. The structural, social, interpersonal, and personal factors that link to amphetamine-group substance use and HIV risk are poorly understood. 13 studies, with a cumulative sample size of 1997 individuals, qualified for the meta-analysis. Overall, high-intensity behavioural interventions were moderately effective in reducing use of amphetamine-group substances (effect size 0.28, 95% CI 0.13-0.44). We did not find conclusive evidence that behavioural interventions as a group are more effective than are passive or minium treatment for reduction of amphetamine-group substance use or sexual risk behaviours. The search for effective, scalable, and sustainable interventions for amphetamine-group substance use, including pharmacotherapies, should be supported and encouraged.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)60753-2

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 137 references

Research works printed but not linked: 1

  1. Paquette M, Das-Douglas M, Boland M, Pappas L, Leonard J, Colfax G. Resist meth: a public health department, advertising agency, and community collaboration to develop a social marketing campaign to address methamphetamine use among MSM. XVII International AIDS Conference; Mexico City, Mexico; Aug 3–8, 2008.

Cited by

Sorted by citations

Items 101–101 of 101

Related

See all

Metadata

Authors
Colfax, G., Santos, G.-M., Chu, P., Vittinghoff, E., Pluddemann, A., Kumar, S., & Hart, C.
Affiliations
  • University of California, San Francisco (US)
  • San Francisco Department of Public Health (US)
  • Columbia University (US)
Corresponding author
Colfax, Grant
ORCID
Venue
The Lancet
Publisher
Elsevier BV
Published
2010-08
Volume
376
Issue
9739
Pages
458-474
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(10)60753-2
OpenAlex
W2120564358
Cited by
167
References
137
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 13 · 2020: 13 · 2019: 10 · 2018: 11 · 2017: 10 · 2016: 13 · 2015: 17 · 2014: 14 · 2013: 18 · 2012: 14
FWCI
1.74
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (R01DA022155, R01DA022190, R01DA023387)
Topics
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
stimulant use, HIV risk, men who have sex with men, behavioral interventions, substance use reduction, sexual risk behavior, non-injection drug use, HIV prevention
MeSH terms
Behavior Therapy, Humans, Risk-Taking, Sexual Behavior, HIV Infections, Substance Abuse, Intravenous, Prevalence, Randomized Controlled Trials as Topic, Needle-Exchange Programs, Amphetamine-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review